KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Share-based Compensation (2016 - 2025)

Cvs Health's Share-based Compensation history spans 17 years, with the latest figure at $135.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 1.46% year-over-year to $135.0 million, compared with a TTM value of $535.0 million through Dec 2025, down 0.93%, and an annual FY2025 reading of $535.0 million, down 0.93% over the prior year.
  • Share-based Compensation for Q4 2025 was $135.0 million at Cvs Health, down from $138.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $204.0 million in Q2 2023, with the low at $87.0 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $129.7 million, with a median of $134.0 million recorded in 2024.
  • Year-over-year, Share-based Compensation surged 74.7% in 2021 and then plummeted 34.8% in 2024.
  • Tracing CVS's Share-based Compensation over 5 years: stood at $138.0 million in 2021, then dropped by 23.19% to $106.0 million in 2022, then increased by 19.81% to $127.0 million in 2023, then rose by 7.87% to $137.0 million in 2024, then dropped by 1.46% to $135.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Share-based Compensation are $135.0 million (Q4 2025), $138.0 million (Q3 2025), and $136.0 million (Q2 2025).